Meeder Asset Management »

Tg Therapeutics shares owned by Meeder Asset Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Meeder Asset Management from 13F filings

Historical chart of Meeder Asset Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Meeder Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Meeder Asset Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.8k 50 36.00
2025-03-31 $947k 24k 39.42
2024-12-31 $2.2k 74 30.09
2023-03-31 $12k 803 15.04
2021-03-31 $129k 2.6k 50.00
2020-09-30 $121k 5.6k 21.74
2020-06-30 $127k 5.3k 23.81
2020-03-31 $21k 2.1k 9.86
2019-06-30 $5.0k 622 8.04
2017-06-30 $3.0k 315 9.52
2017-03-31 $4.0k 315 12.70
2016-12-31 $16k 3.4k 4.73